Allen J. Dozor, MD, from New York Medical College, answers our questions about his work in developing high-risk asthma programs, and explains how other practitioners can implement similar programs.
The lead authors of a new study about the 20-year financial and health burdens of asthma—J. Mark FitzGerald, MD, and Mohsen Sadatsafavi, MD, PhD—answer our questions about its findings.
Claudia Crimi, MD, PhD, and colleagues recently compared Asthma Control Test scores obtained by patients vs physicians. The research highlights the need for physicians to carefully evaluate patients'...
Vanessa Kronzer, MD, from the Mayo Clinic, answers our questions about her study that assessed the association between rheumatoid arthritis, asthma, passive smoke exposure, and more.
Biologic therapies have been introduced as new treatment options for patients with severe asthma. Wendy Moore, MD, answered our questions about the research she presented at CHEST2020.
Recent updates to the major asthma guidelines have left physicians with questions on how to put these new recommendations into practice. In her session at CHEST2020, Meghan Althoff, MD, PhD, discussed the...
Diego J. Maselli, MD, answers our questions about choosing the right biologic for patients with severe asthma, the costs of biologics, and challenges to patient adherence to these therapies.
A new study found that the use of e-cigarette flavorings is associated with an increased risk of serious cardiovascular consequences. Consultant360 spoke with lead study author Jessica Fetterman, PhD, about...
Najee Richardson, who finished in the top 3 for American Ninja Warrior, answers our questions about overcoming his asthma diagnosis to become one of the world’s top athletes.
